Arrowhead Research | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Arrowhead Research USD 52.59M 132.85M 2024-12
Incyte USD 3.67B 219.94M 2025-03
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Ligand Pharmaceuticals USD 830.44M 10.74M 2024-12
Merck USD 46.31B 1.81B 2024-12
Moderna USD 10.07B 835M 2025-03
Novartis USD 44.05B 605M 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
TG Therapeutics USD 222.36M 30.21M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12
Xencor USD 677.61M 46.22M 2024-12



Arrowhead Research Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.